Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 12, 2018
Pharmacogenetics of angiotensin-converting enzyme inhibitor-induced angioedemaYusmiati Liau, Ignatius Chua, Martin A Kennedy, et al.Pharmacogenomics|September 28, 2019
Nanopore sequencing of the pharmacogene <i>CYP2D6</i> allows simultaneous haplotyping and detection of duplicationsYusmiati Liau, Simran Maggo, Allison L Miller, et al.Pharmacogenetics and Genomics|October 1, 2019
A multiplex pharmacogenetics assay using the MinION nanopore sequencing deviceYusmiati Liau, Simone L Cree, Simran Maggo, et al.BMC Genomics|December 23, 2024
Low-pass nanopore sequencing for measurement of global methylation levels in plantsYusmiati Liau, Annabel Whibley, Amy M Hill, et al.Epigenetics & Chromatin|March 25, 2021
Genome-wide impact of hydrogen peroxide on maintenance DNA methylation in replicating cellsAnnika R Seddon, Yusmiati Liau, Paul E Pace, et al.Frontiers in Plant Science|January 26, 2026
Assessing the efficacy of thermotherapy combined with chemotherapy or cryotherapy for the eradication of grapevine leafroll-associated virus 3Solomon Peter Wante, Kar Mun Chooi, Ranjith Pathirana, et al.Scientific Reports|August 22, 2019
Contrasting signals of cardiovascular health among natriuretic peptides in subjects without heart diseaseTimothy C R Prickett, Janet K Spittlehouse, Allison L Miller, et al.Journal of Phycology|October 22, 2024
A cry for kelp: Evidence for polyphenolic inhibition of Oxford Nanopore sequencing of brown algaeWilliam S Pearman, Vanessa Arranz, Jose I Carvajal, et al.Frontiers in Genetics|October 31, 2022
Allelic diversity of the pharmacogene CYP2D6 in New Zealand Māori and Pacific peoplesLeonie M Hitchman, Allamanda Faatoese, Tony R Merriman, et al.Pageof 1